Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oncternal Therapeutics, Inc. has filed 1,606 SEC EDGAR filings since 21 Aug 2003

SEC filing history

Showing 976-1,000 of 1,000 matching filings.

Per page
25
Current page
40
4

FORM 4 SUBMISSION

Filing date
06 Jul 2010
Reporting date
01 Jul 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Jun 2010
Reporting date
25 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jun 2010
Reporting date
22 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-79588

SCHEDULE 13D/A

Filing date
21 Jun 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

FORM 8-K

Filing date
21 Jun 2010
Reporting date
21 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jun 2010
Reporting date
15 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
14 Jun 2010
Reporting date
27 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

FORM 8-K

Filing date
09 Jun 2010
Reporting date
09 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

FORM 8-K

Filing date
09 Jun 2010
Reporting date
09 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-79588

SCHEDULE 13D/A

Filing date
09 Jun 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jun 2010
Reporting date
07 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Jun 2010
Reporting date
03 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-50549

CT ORDER filing

Filing date
07 Jun 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jun 2010
Reporting date
01 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jun 2010
Reporting date
27 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
01 Jun 2010
Reporting date
27 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 May 2010
Reporting date
27 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

FORM 8-K

Filing date
26 May 2010
Reporting date
26 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 May 2010
Reporting date
17 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 May 2010
Reporting date
13 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 May 2010
Reporting date
11 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 May 2010
Reporting date
07 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 May 2010
Reporting date
05 May 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 May 2010
Reporting date
30 Apr 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 May 2010
Reporting date
30 Apr 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .